Should You Buy Tilray Stock Under $5?
Tilray reported record revenue and adjusted EBITDA for its just-completed fiscal year, yet its shares are down nearly 56% year to date. The article attributes the continued decline to two factors: recreational cannabis making up too little of total revenue, and an unresolved share dilution problem.
Why it matters — TLRY watchers would care because despite strong headline results, the stock's slide stems from concerns over revenue mix and persistent dilution that could continue to weigh on shareholder value.